However, in mice with CKD, rhEpo injections resulted in elevated circulating total FGF-23, more than levels of iFGF-23, suggesting the coupling of increased FGF-23 production with increased proteolytic cleavage [141]. This evidence concerns the gene FGF23 and chronic kidney disease.